← Back to Analyst Consensus 
VTVT Buy
vTv Therapeutics Inc.
Current Price —
Implied Upside —
Analysts 11
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 1 reiterations from 1 firms
Next Earnings
Nov 4, 2026 (8 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 14, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Aug 6, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Jul 16, 2026 | BTIG | maintain | Buy → Buy | — | 52% |
| Mar 12, 2026 | Evercore ISI Group | initiate | — → Outperform | — | 58% |
| Mar 11, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Jan 27, 2026 | BTIG | maintain | Buy → Buy | $49 | 52% |
| Jan 23, 2026 | Roth Capital | initiate | — → Buy | $58 | 52% |
| Jan 5, 2026 | TD Cowen | initiate | — → Buy | $67 | 54% |
| Dec 19, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $47 | 44% |
| Nov 19, 2025 | BTIG | initiate | — → Buy | $40 | 52% |
| Aug 13, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $36 | 44% |
| Apr 9, 2025 | HC Wainwright & Co. | initiate | — → Buy | $36 | 44% |
| Dec 9, 2024 | Alliance Global Partners | initiate | — → Buy | $35 | 41% |
Price Target Trend
Apr 21, 2026 Latest: $56 Oct 25, 2026
EPS Estimates
+1y $-4.38
Lo: $-7.81 Hi: $-2.46
7 analysts ▲1
0y $-1.71
Lo: $-4.20 Hi: $-0.40
6 analysts ▲1
+1q $-1.05
Lo: $-1.32 Hi: $-0.73
6 analysts ▲2
0q $-1.06
Lo: $-1.29 Hi: $-0.67
6 analysts ▲1
Cross-Platform Signals
No cross-platform signals in the last 90 days